The role of the Biostatistics Core Component (BBC) of the program project grant is to serve as a centralized resource to the investigators of the program project for Bone Marrow Transplantation for Hematologic Malignancies, to provide data management services and biostatistical consultation as needed.
The specific aims of the BBC are: 1. To assist in the planning of the projects of the grant, including study design, sample size projections, randomization, analytic plan and statistical methodology. 2. To provide protocol management and data collection for the clinical studies of the program project. 3. To provide database management and computerization of data for both the basic science and clinical studies. 4. To perform quality control assurance of the data collection and computerization, including routine audits of in-house protocol data. 5. To perform statistical analysis of study results, and collaborate in the writing of manuscripts reporting these data. The BBC staff will consist of the Principal Investigator, Ph.D. Biostatistician, MS. Biostatistician, Database Coordinator, and 3.4 Data Managers. Mechanisms are currently in place for providing randomization, study design, protocol review, protocol and data management, audits of in- house protocols, data requests and statistical analyses. Analyses will be performed using the SAS and BMDT software packages, as well as other software for specialized applications. Computer resources are available to the BBC via a local area network of personal computers within the Department of Biostatistics. In addition links to the fiber optic cabling at COH allow inter-connection with any other network or mainframe on campus. A clinical trials software program (the Biostatistics Information Tracking System BITS) has been developed in-house, and currently contains over 1800 records of data on bone marrow transplant patients. The BCC has developed customized data collection instruments and databases specific to the following: autologous BMT lymphoma patients, autologous BMT leukemia patients, related/unrelated donor transplants, radioimmunotherapy patients, induction therapy for ANLL patients, quality of life results and follow-up information. These data are linked with the accession/randomization information residing in BITS, and automated flowsheets have been programmed by downloading Laboratory data from the SunQuest lab system. Statistical analyses performed during the current funding period have let to numerous collaborative publications. The BCC has had input into all of the designs for the specific aims of the current proposal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA030206-18
Application #
6102100
Study Section
Project Start
1999-02-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
18
Fiscal Year
1999
Total Cost
Indirect Cost
Name
City of Hope National Medical Center
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Limaye, Ajit P; La Rosa, Corinna; Longmate, Jeff et al. (2016) Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients. Transplantation 100:210-6
Jonnalagadda, Mahesh; Mardiros, Armen; Urak, Ryan et al. (2015) Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther 23:757-68
Wang, Xiuli; Wong, ChingLam W; Urak, Ryan et al. (2015) CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells. Clin Cancer Res 21:2993-3002
Mardiros, Armen; Forman, Stephen J; Budde, Lihua E (2015) T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia. Curr Opin Hematol 22:484-8
Caruso, Hillary G; Hurton, Lenka V; Najjar, Amer et al. (2015) Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity. Cancer Res 75:3505-18
Israyelyan, A; Goldstein, L; Tsai, W et al. (2015) Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation. Bone Marrow Transplant 50:26-33
Wussow, Felix; Chiuppesi, Flavia; Martinez, Joy et al. (2014) Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. PLoS Pathog 10:e1004524
Rushworth, David; Jena, Bipulendu; Olivares, Simon et al. (2014) Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificity. J Immunother 37:204-13
Jena, Bipulendu; Moyes, Judy S; Huls, Helen et al. (2014) Driving CAR-based T-cell therapy to success. Curr Hematol Malig Rep 9:50-6
Singh, Harjeet; Huls, Helen; Kebriaei, Partow et al. (2014) A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19. Immunol Rev 257:181-90

Showing the most recent 10 out of 364 publications